LMRI (Lumexa Imaging Holdings, Inc. Common Stock) Stock Analysis - Analyst Ratings

Lumexa Imaging Holdings, Inc. Common Stock (LMRI) is a publicly traded the market company. As of May 21, 2026, LMRI trades at $7.37 with a market cap of $650.47M and a P/E ratio of 362.75. LMRI moved +5.71% today. Year to date, LMRI is -56.03%; over the trailing twelve months it is flat. Its 52-week range spans $6.45 to $19.45. Analyst consensus is strong buy with an average price target of $17.00. Rallies surfaces LMRI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate LMRI?

4 analysts cover LMRI: 0 strong buy, 4 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $17.00.

LMRI Key Metrics

Key financial metrics for LMRI
MetricValue
Price$7.37
Market Cap$650.47M
P/E Ratio362.75
EPS$0.02
Dividend Yield0.00%
52-Week High$19.45
52-Week Low$6.45
Volume792
Avg Volume0
Revenue (TTM)$252.54M
Net Income$1.72M
Gross Margin0.00%

LMRI Analyst Consensus

4 analysts cover LMRI: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $17.00.

Latest LMRI News

Recent LMRI Insider Trades

  • Cooper Henry Lee bought 30.00K (~$223.11K) on May 14, 2026.

Common questions about LMRI

What do analysts rate LMRI?
4 analysts cover LMRI: 0 strong buy, 4 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $17.00.
Does Rallies show LMRI price targets?
Yes. Rallies tracks LMRI analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is LMRI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for LMRI. It does not provide personalized investment advice.
LMRI

LMRI